Elucidating the Origin of Heterogeneous Anomalous Diffusion in the
  Cytoplasm of Mammalian Cells by Sabri, Adal et al.
ar
X
iv
:1
91
0.
00
10
2v
2 
 [p
hy
sic
s.b
io-
ph
]  
5 J
ul 
20
20
Elucidating the origin of heterogeneous anomalous diffusion in the cytoplasm of
mammalian cells
Adal Sabri1, Xinran Xu2, Diego Krapf 2,3,∗, and Matthias Weiss1, ∗
1Experimental Physics I, University of Bayreuth, D-95440 Bayreuth, Germany
2Dept. of Electrical and Computer Engineering, and 3School of Biomedical Engineering,
Colorado State University, Fort Collins, CO 80523, USA
Diffusion of tracer particles in the cytoplasm of mammalian cells is often anomalous with a
marked heterogeneity even within individual particle trajectories. Despite considerable efforts, the
mechanisms behind these observations have remained largely elusive. To tackle this problem, we
performed extensive single-particle tracking experiments on quantum dots in the cytoplasm of living
mammalian cells at varying conditions. Analyses of the trajectories reveal a strong, microtubule-
dependent subdiffusion with antipersistent increments and a substantial heterogeneity. Furthermore,
particles stochastically switch between different mobility states, most likely due to transient asso-
ciations with the cytoskeleton-shaken endoplasmic reticulum network. Comparison to simulations
highlight that all experimental observations can be fully described by an intermittent fractional
Brownian motion, alternating between two states of different mobility.
The cytoplasm of mammalian cells is a complex aque-
ous environment, crowded with large amounts of macro-
molecules [1, 2] and a multitude of membrane-enveloped
organelles of largely varying sizes. Diffusion of suppos-
edly inert tracer particles in the cytoplasm of living cells
has frequently been reported to be anomalous with a sub-
linear scaling of the mean square displacement (MSD),
〈r2(τ)〉 ∼ tα (α < 1) on spatio-temporal scales below a
few micrometers and several seconds [3–5]. The emer-
gence of subdiffusive motion appears in many cases to
be consistent with a stochastic process of the fractional
Brownian motion (FBM) type [6–8], i.e. a self-similar
Gaussian process with stationary increments whose fea-
tures are determined by the Hurst coefficient H = α/2
[9]. FBM dynamics is subdiffusive for 0 < H < 1/2 and
trajectories are characterized by antipersistent, i.e. an-
ticorrelated, increments. A plausible interpretation for
such antipersistent memory effects is a viscoelastic en-
vironment [10–15] with a complex shear modulus that
scales as G(ω) ∼ ωα, where the elastic and the viscous
parts are responsible for the FBMmemory and for energy
dissipation, respectively.
Subdiffusion has long been recognized to emerge in so-
lutions crowded with macromolecules, with an anomaly
exponent α that decreases with crowder concentration
[16, 17]. However, the value of α is often observed to
be considerably lower in the cytoplasm than in similarly
crowded artificially fluids, e.g. α ≈ 0.6 [10, 18] versus
α ≈ 0.8 [11, 14]. Therefore, it is currently understood
that subdiffusion in the cytoplasm may not be caused
solely by macromolecular crowding but also relies on ad-
ditional mechanisms. As of yet, no general agreement
exists for a physical model that can reliably describe cy-
toplasmic subdiffusion in detail. Further, subdiffusion is
not universal but depends on tracer size, e.g. for particles
in reconstituted entangled actin filament networks, where
α can be continuously tuned between zero and unity as
a function of particle radius and average mesh size [19].
Beyond such caging effects, it has also been proposed
that non-inert crowders may strongly alter the dynamics
of cytoplasmic particles [20, 21]. Extensive Monte Carlo
simulations have supported this hypothesis [22]. More re-
cently, also experimental support has been obtained via
single-particle tracking (SPT) on surface-modified tracer
particles in the cytoplasm of HeLa cells: The emergence
of subdiffusion and the value of α was shown to depend
both on particle size and non-specific interactions to the
cytoplasmic interior [18]. Yet, the identity of the cyto-
plasmic binding partners that enforce the emergence of
subdiffusive motion has remained elusive. Potential can-
didates include the cytoskeleton and organelles, e.g. the
endoplasmic reticulum (ER) network that pervades the
cytoplasm [23].
Further, local variations in complex media are notice-
able in the motion of particles therein: (Sub)diffusion
in cellular fluids has been observed to be heterogeneous
even within individual trajectories [24–26], suggesting
heterogeneous diffusion processes [27] or spatiotempo-
ral variations of transport coefficients [28–30]. Despite
the elegance of these theoretical models, it remains an
open question how a distribution of apparent diffusivi-
ties emerges in the first place. A potential source might
be the ambient active noise in the cytoplasm, i.e. the
chemically induced rattling and shaking of the environ-
ment due to the non-equilibrium action of molecular mo-
tors and cytoskeletal filaments. In fact, breaking down
cytoskeletal filaments alters the subdiffusive motion of
organelle structures in mammalian cells [31, 32] and also
compromises the superdiffusive motion of beads in mi-
grating amoebae [26]. Taken together, it is currently nei-
ther clear (i) which mechanism regulates the value of the
anomaly exponent α in the cytoplasm nor (ii) how one
should picture the emergence of heterogeneous subdiffu-
sion due to non-specific interactions in an actively driven
environment.
Here, we address these points by extensive SPT ex-
2periments on individual quantum dots loaded into the
cytoplasm of living mammalian cells. In particular, we
quantify the particles’ motion in the cytoplasm of un-
treated cells and in cells where the actin or microtubule
cytoskeleton, or the ER has been disrupted. In all cases, a
distinct and heterogeneous subdiffusion of tracers is seen.
The subdiffusion effects become more pronounced when
microtubules are broken down. Detailed analyses reveal
that particles switch stochastically between at least two
mobility states, irrespective of the cytoskeleton integrity,
but clearly dependent on the presence of an intact ER
network. This evidence suggests non-specific binding of
tracers to the ER network, and hence an indirect coupling
to active microtubule-based processes, to be responsible
for the observed heterogeneous subdiffusion in the cy-
toplasm. Our experimental data are well described by
an intermittent FBM model that switches stochastically
between a higher and lower mobility, supposedly repre-
senting free motion in the cytosol and co-movement with
ER segments.
To explore the heterogeneous subdiffusion in the cyto-
plasm of mammalian cells, we performed extensive SPT
on quantum dots that had been introduced into the cy-
toplasm of cultured HeLa cells by bead loading [33, 34].
Measurements were performed with a sampling time of
∆t = 100 ms, and quantum dot trajectories were first
evaluated in terms of their time-averaged MSD (TA-
MSD) using N = 100 or N = 500 positions,
〈r2(τ)〉t = 1
N − k
N−k∑
i=1
[r((i + k)∆t)− r(i∆t)]2 . (1)
Following previous reports [18, 35, 36], individual TA-
MSDs were fitted with a simple power law 〈r2(τ)〉t =
Kατ
α in the range ∆t ≤ τ ≤ 10∆t to extract the
anomaly exponent α and the generalized diffusion coef-
ficient Kα. The resulting probability density function
(PDF) of anomaly exponents, p(α), showed consider-
able trajectory-to-trajectory fluctuations around a mean
〈α〉 ≈ 0.57 (Fig. 1 and Fig. S1a in [34]) that slightly
depends on the trajectory length N (Table I). Control
experiments in highly viscous artificial solutions yielded
〈α〉 ≈ 1 (Sect. C and Fig. S2f,g in [34]).
To probe a potential perturbation of the power-law
scaling due to static and dynamic localization errors [37],
and to validate the significance of the mean exponent
〈α〉, we exploited a bootstrapping approach [34]: From
the whole set of calculated TA-MSDs we drew randomly
a non-exhaustive ensemble of 100 curves, averaged these
geometrically, and used again a simple power-law fit to
extract the scaling exponent α of the resulting ensemble-
averaged TA-MSD. Repeating this approach M = 200
times, we noted that none of the ensemble-averaged TA-
MSDs showed a significant offset in the limit τ → 0
(Sect. E and Fig. S2a-d in [34]). Hence, positive and
negative contributions from static and dynamic localiza-
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FIG. 1: The PDF of anomaly exponents α, obtained from
individual TA-MSDs (N = 100), shows a broad variation
around a mean 〈α〉 = 0.59 in untreated cells (black his-
togram). Nocodazole-treated cells have a similarly broad
PDF (red histogram) with a significantly lower mean (cf.
Table I). Similar results are found for longer trajectories
(Fig. S1a in [34]). Using a bootstrapping approach with ge-
ometric averaging (diamonds; full lines are Gaussian fits) re-
sulted in narrower PDFs with the same mean, 〈α〉.
untreat. noc cyto D lat A
TA-MSDs 0.59 (0.55) 0.46 (0.36) 0.58 (0.54) 0.62 (0.58)
b.tr. geom. 0.58 (0.55) 0.46 (0.36) 0.58 (0.54) 0.61 (0.57)
b.tr. arith. 0.79 (0.60) 0.66 (0.43) 0.82 (0.73) 0.86 (0.76)
TABLE I: Mean anomaly exponents 〈α〉 for trajectories of
length N = 100 (N = 500) in untreated cells and after appli-
cation of nocodazole, cytochalasin D, or latrunculin A. Stan-
dard errors were in all cases smaller than 0.02.
tion errors appear to cancel each other in our data and
therefore fitting with a simple power law gives meaningful
results for α.
The PDF of α values obtained with the bootstrapping
approach (Fig. 1) was very narrow with a mean 〈α〉 that
matched the respective value found before via individual
TA-MSDs (Table I). Geometric averaging of TA-MSDs
boils down to an arithmetic averaging of individual α
values (but not of Kα). Thus, the narrow width of p(α)
after bootstrapping is determined by σ/
√
M , where σ is
the standard deviation of α derived from individual TA-
MSDs. Analyzing TA-MSDs with a recently introduced
and validated resampling algorithm [38] confirmed the
values for 〈α〉 [34]. An arithmetic instead of a geometric
averaging of TA-MSDs lead to an overestimation of the
mean scaling exponent (Table I and Fig. S1b in [34]).
Being interested in how cytoplasmic diffusion is af-
fected by the cytoskeleton, we applied either nocoda-
zole to break down microtubules, or cytochalasin D or
latrunculin A to disrupt actin filaments. Disrupting mi-
crotubules changed the diffusion anomaly substantially
(Fig. 1 and Table I) whereas disrupting actin networks
3had no significant effect (Table I). Transport coefficients
Kα showed a higher sensitivity to microtubule disrup-
tion and also a stronger dependence on trajectory length
(Fig. S1c in [34]). Similar to previous observations on the
dynamics of the ER [32], the effect of nocodazole on Kα
was not particularly strong for short trajectories. For
longer trajectories, however, a marked shift to smaller
transport coefficients was visible upon microtubule dis-
ruption. This puts up a caveat that longer trajectories
may represent a distinct subset of the acquired data, e.g.
a lower mobility facilitating the tracking, but it also indi-
cates that microtubule-associated processes significantly
contribute to the diffusion anomaly in untreated cells be-
yond a change in the scaling of MSDs.
Going beyond the MSD, we analyzed the ensemble av-
erage of the velocity autocorrelation function (VACF),
Cv(τ) = 〈v(t)v(t + τ)〉t,E (2)
that is highly sensitive to the nature of unconfined
anomalous diffusion processes [39, 40]. Here, v(t) =
[r(t + δt) − r(t)]/δt is the velocity at time t, given via
the increments in a period δt. Varying δt = k∆t in mul-
tiples of the sampling time ∆t, the VACFs showed in all
cases a pronounced negative peak for τ = δt as expected
for antipersistent random walks. By rescaling the times
as ξ = τ/δt, all VACF traces collapse to a single mas-
ter curve that agrees with the analytical predictions for
FBM (Fig. 2 and Fig. S3a in [34]), namely
Cv(ξ) = {(ξ + 1)α + |ξ − 1|α − 2ξα} /2 , (3)
with α being set to the value 〈α〉 found with the boot-
strapping protocol (Table I). We emphasize the excep-
tional agreement of the experimental data with Eq. (3)
without any fitting parameters since other antipersistent
random walk data, e.g. from membrane proteins, can de-
viate significantly from the FBM prediction (see Fig. S3b
[34] for an example).
Next we inspected the PDF of the normalized in-
crements χ within a time lag δt [25], i.e. time series
∆xi = xi+k−xi and ∆yi = yi+k−yi were calculated and
normalized by their individual root-mean-square step
length. Since no systematic differences were observed
between x- and y-directions, all normalized increments
were combined into a single set of χ. For a homogeneous
FBM, a Gaussian PDF p(χ) is expected for all δt. Yet,
for small δt our data showed significant deviations from
a Gaussian in the tails of the distribution (Fig. 3a and
Fig. S4a in [34]). This suggests that individual trajecto-
ries are heterogeneous, i.e. the particle mobility changes
within the trajectory. For δt = 10∆t, this heterogeneity
subsides, collapsing the increment statistics to the antic-
ipated Gaussian (Fig. S4b in [34]).
To directly probe switching between different mobili-
ties, we analyzed the local convex hull (LCH) of individ-
ual trajectries [34, 41]: After normalizing the trajectories
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FIG. 2: Rescaled normalized VACFs [Eq. (2)] of all experi-
mental trajectories with N = 100 at different δt agree with
the analytical prediction for FBM (full lines, Eq. (3)), with-
out treatment (grey symbols) and after nocodazole-treatment
(red symbols). For better visibility, untreated cell data have
been shifted upwards. No significant differences are seen for
longer trajectories (Fig. S3a in [34]). An estimate of 〈α〉 can
be directly obtained from the VACF minimum, Cv(ξ = 1) =
2α−1−1. VACF minima for untreated and nocodazole-treated
cells yield α = 0.58±0.01 and α = 0.38±0.02, respectively, in
favorable agreement with our MSD results. Inset: VACFs of
simulated intermittent FBM trajectories (N = 100, anomaly
parameter α0) also agree with Eq. (3) (full lines).
by their root-mean-square step length, we determined for
each trajectory the largest diameter Sd(t) of the LCH for
positions visited in the period [t−2∆, t+2∆] (see Fig. 3b
for illustration). Using the mean µ and standard devi-
ation σ of all Sd values for a given cell condition, we
defined a threshold µ + σ and rated particles to be in a
more mobile state for Sd(t) ≥ µ + σ (see also Fig. S6 in
[34]). As a result, we observed a frequent switching be-
tween a lower- and a higher-mobility state (named ’on’
and ’off’, respectively) with markedly larger mean resi-
dence times τ in the low-mobility state, irrespective of
any treatment (see PDFs p(τ) in Fig. 3c). Employing a
threshold µ+ σ, all trajectories exhibit switching behav-
ior. However, upon increasing the threshold, a growing
fraction of trajectories does not display any switching
(Fig. 3d) while no substantial difference is seen in the
mean residence times (see Fig. S6c in [34]). Hence, the
LCH analysis confirms the existence of at least two mo-
bility states for untreated and nocodazole-treated cells.
Additional support for a switching behavior is given by
the autocorrelation function of squared increments, G(τ),
which shows a long-lasting decay (Sect. G and Fig. S5 in
[34]).
Based on these results and previous observations on
the cytoskleton-dependent anomalous dynamics of ER
junctions [32], we hypothesized that particle interactions
with the ubiquitous ER network are key for the observed
switching of mobilities. We therefore repeated tracking
4(a) (b)
(c) (d)
0 2 4
10-4
10-3
10-2
10-1
|χ|
p(|χ|)
δt=∆t
p(τ)
τ/∆t0 20 40 60
10-3
10-2
10-1
+noc
on-state
off-state
ctrl
0
1
2
Sd(t)
t/∆t0 20 40 60
µ+σ
µ+1σ µ+2σ µ+3σ µ+4σ
0.0
0.2
0.4
0.6
0.8
1.0
f(no switch)
threshold
+noc
+filipin
ctrl
FIG. 3: (a) PDFs of normalized increments (time lag δt = ∆t,
shown here as moduli, |χ|) follow the anticipated Gaussian
(green dashed line) for small |χ| but show significant devia-
tions for |χ| > 3.5, indicating a heterogeneous process (black
circles and red crosses: untreated and nocodazole-treated
cells). These data are in excellent agreement with simula-
tions of an intermittent FBM model (α0 = 0.5 and α0 = 0.3:
coinciding light and dark blue lines). (b) Representative tra-
jectory (color-coded successive positions) with a local convex
hull (LCH) at t = 28∆t highlighted in grey. The correspond-
ing time series of largest LCH diameters, Sd(t), shows consid-
erable fluctuations. Values Sd(t) ≥ µ+ σ (dashed horizontal
line) are rated to be in the more mobile ’off’-state. (c) Res-
idence times in the low- and high-mobility state, extracted
from individual trajectories (threshold θ = µ+ σ) feature ex-
ponential PDFs (full black lines) with a substantially longer
mean residence time in the ’on’-state. No substantial differ-
ences are seen for nocodazole-treatment or when choosing a
threshold θ = µ + 2σ (Fig. S6c in [34]). (d) The fraction of
trajectories without any switching rises when successively in-
creasing the threshold value to θ = µ+4σ. No significant dif-
ferences are seen between untreated (black horizontal stripes)
and nocodazole-treated cells (filled red circles). In contrast,
trajectories from filipin-treated cells (open blue squares) fea-
ture a much stronger increase (highlighted by dashed lines),
indicating that ER structures are required for the mobility
switching.
experiments in cells where the ER network had been frag-
mented either using the drug filipin [34, 42] or by an os-
motic shock [34, 43] (see Fig. 4). We observed that a lack
of ER tubules did not grossly alter the scaling exponent
〈α〉 ∼ 0.6. Yet, the intermittent nature of the particle
motion was markedly reduced as evidenced by the LCH
analysis (Fig. 3d), i.e. trajectories with a switching of
mobilities become more rapidly diminished when altering
the threshold for Sd(t). This indicates that association to
and dissociation from ER tubules is involved in creating
(b)(a) (c)
FIG. 4: Representative fluorescence images of the ER in (a)
untreated, (b) filipin-treated, and (c) osmotically shocked
cells. In line with previous reports [42, 43], the ER network
of untreated cells is completely fragmented after filipin treat-
ment or osmotic shock. Scale bars: 10 µm.
the intermittent nature of the particles’ diffusion.
Having observed a heterogeneous, intermittent, ER-
and cytoskeleton-dependent subdiffusion of quantum
dots in the cytoplasm, we used Occam’s razor to formu-
late the simplest model that can capture our experimen-
tal data (see [34] for a discussion of more elaborate mod-
els). Taking all experimental constraints into account,
we arrived at an intermittent FBM model: We modeled
the dynamics of individual particles as FBM with fixed
anomaly α0 and a transport coefficient that randomly
switches within each trajectory [34]. Particles were as-
sumed to exist in ’on’ and ’off’ states with transport co-
efficients Konα < K
off
α , representing ER-tubule associated
and free motion. Dichotomous switching between these
states was modeled as a Markov process with transition
rates kon and koff. In our simulations we kept these rates
and the ratio s = Konα /K
off
α fixed, and chose α0 = 0.5
(α0 = 0.3) for untreated (nocodazole-treated) cells, in ac-
cordance with the previously reported anomaly values for
ER junctions [32]. Despite the simplicity of this model,
we observed a surprisingly good overlap with our exper-
imental data when choosing s = 3.5, kon = 0.27 s
−1, and
koff = 0.01 s
−1: First, the mean anomaly of simulated
realizations, extracted from TA-MSDs, was 〈α〉 = 0.55
and 〈α〉 = 0.37, respectively, in agreement with experi-
mental observations (Table I). The slightly larger value
as compared to the imposed value α0 is a consequence of
the dichotomous switching that perturbs the pure FBM
behavior. Second, when using the respective value 〈α〉,
the VACF showed the same agreement with Eq. (3) as
the experimental data (insets of Fig. 2 and Fig. S3a in
[34]). Third, the non-Gaussian shape of the increment
χ statistics for δt = ∆t and a more Gaussian shape for
δt = 10∆t are almost perfectly matched (Fig. 3a and
Fig. S4 in [34]). Fourth, the shape of G(τ) overlapped
very well with the experimental data (Fig. S5 in [34]).
Moreover, the PDFs of residence times in the ’on’ and
’off’ states were in favorable agreement with our exper-
imental results (Sect. F in [34]). We therefore conclude
that our minimal model is sufficient for reproducing the
5features of our experimental data.
In summary, we have observed a heterogeneous and
intermittent subdiffusion of quantum dots in the cyto-
plasm of living cells that was altered upon disrupting
microtubules or fragmenting the ER network. Our ex-
perimental data are well described by a simple intermit-
tent FBM model in which we have set the anomaly expo-
nents to those observed for the motion of ER junctions
in untreated and nocodazole-treated cells. Combining all
insights, we arrive at the conclusion that transient asso-
ciation with ER membranes hampers free diffusion of the
particles, hence enforcing a particularly low anomaly ex-
ponent α. If the ER network is intact, association with
ER tubules leads to an intermittent diffusion process of
particles and couples their motion indirectly to active
microtubule-based processes. The persisting, strongly
subdiffusive type of motion after fragmenting the ER net-
work hints at additional structures with which particles
might interact, e.g. networks of intermediate filaments
[44] or (ER-derived) membrane vesicles that mimic a mi-
croemulsion [45]. Thus, subdiffusion in the cytoplasm is
indeed a considerably more complex phenomenon than
anomalous diffusion in artificial fluids crowded with pas-
sive macromolecules.
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